Solly K - Search Results

1

The inwardly rectifying potassium channel Kir1.1: development of functional assays to identify and characterize channel inhibitors.

Felix JP, Priest BT, Solly K, Bailey T, Brochu RM, Liu CJ, Kohler MG, Kiss L, Alonso-Galicia M, Tang H, Pasternak A, Kaczorowski GJ, Garcia ML. Felix JP, et al. Among authors: solly k. Assay Drug Dev Technol. 2012 Oct;10(5):417-31. doi: 10.1089/adt.2012.462. Epub 2012 Aug 10. Assay Drug Dev Technol. 2012. PMID: 22881347

2

Miniaturization and HTS of a FRET-based membrane potential assay for K(ir) channel inhibitors.

Solly K, Cassaday J, Felix JP, Garcia ML, Ferrer M, Strulovici B, Kiss L. Solly K, et al. Assay Drug Dev Technol. 2008 Apr;6(2):225-34. doi: 10.1089/adt.2008.123. Assay Drug Dev Technol. 2008. PMID: 18471076

3

A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel.

Schmalhofer WA, Swensen AM, Thomas BS, Felix JP, Haedo RJ, Solly K, Kiss L, Kaczorowski GJ, Garcia ML. Schmalhofer WA, et al. Among authors: solly k. Assay Drug Dev Technol. 2010 Dec;8(6):714-26. doi: 10.1089/adt.2010.0351. Assay Drug Dev Technol. 2010. PMID: 21158686

4

Identification of novel and selective Kv2 channel inhibitors.

Herrington J, Solly K, Ratliff KS, Li N, Zhou YP, Howard A, Kiss L, Garcia ML, McManus OB, Deng Q, Desai R, Xiong Y, Kaczorowski GJ. Herrington J, et al. Among authors: solly k. Mol Pharmacol. 2011 Dec;80(6):959-64. doi: 10.1124/mol.111.074831. Epub 2011 Sep 26. Mol Pharmacol. 2011. PMID: 21948463

5

A miniaturized homogenous assay of mitochondrial membrane potential.

Vongs A, Solly KJ, Kiss L, Macneil DJ, Rosenblum CI. Vongs A, et al. Assay Drug Dev Technol. 2011 Aug;9(4):373-81. doi: 10.1089/adt.2010.0301. Epub 2011 Feb 6. Assay Drug Dev Technol. 2011. PMID: 21294696

6

Development and application of a scintillation proximity assay (SPA) for identification of selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.

Mundt S, Solly K, Thieringer R, Hermanowski-Vosatka A. Mundt S, et al. Among authors: solly k. Assay Drug Dev Technol. 2005 Aug;3(4):367-75. doi: 10.1089/adt.2005.3.367. Assay Drug Dev Technol. 2005. PMID: 16180991

7

High-throughput screening of 11beta-hydroxysteroid dehydrogenase type 1 in scintillation proximity assay format.

Solly K, Mundt SS, Zokian HJ, Ding GJ, Hermanowski-Vosatka A, Strulovici B, Zheng W. Solly K, et al. Assay Drug Dev Technol. 2005 Aug;3(4):377-84. doi: 10.1089/adt.2005.3.377. Assay Drug Dev Technol. 2005. PMID: 16180992

8

Application of division arrest technology to cell-based HTS: comparison with frozen and fresh cells.

Kunapuli P, Zheng W, Weber M, Solly K, Mull R, Platchek M, Cong M, Zhong Z, Strulovici B. Kunapuli P, et al. Among authors: solly k. Assay Drug Dev Technol. 2005 Feb;3(1):17-26. doi: 10.1089/adt.2005.3.17. Assay Drug Dev Technol. 2005. PMID: 15798392

9

Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays.

Solly K, Wang X, Xu X, Strulovici B, Zheng W. Solly K, et al. Assay Drug Dev Technol. 2004 Aug;2(4):363-72. doi: 10.1089/adt.2004.2.363. Assay Drug Dev Technol. 2004. PMID: 15357917

10

High-Throughput Screen of GluK1 Receptor Identifies Selective Inhibitors with a Variety of Kinetic Profiles Using Fluorescence and Electrophysiology Assays.

Solly K, Klein R, Rudd M, Holloway MK, Johnson EN, Henze D, Finley MF. Solly K, et al. J Biomol Screen. 2015 Jul;20(6):708-19. doi: 10.1177/1087057115570580. Epub 2015 Feb 19. J Biomol Screen. 2015. PMID: 25700884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters